Literature DB >> 21953080

The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.

Xiaofang Guo1, Qianjin Liao, Pan Chen, Xiayu Li, Wei Xiong, Jian Ma, Xiaoling Li, Zhaohui Luo, Hailin Tang, Min Deng, Yin Zheng, Rong Wang, Wenling Zhang, Guiyuan Li.   

Abstract

PURPOSE: Dysregulation of microRNA (miRNA) metabolism has been observed in a variety of human cancers, but the expression patterns of the enzymes responsible for generating miRNAs remain largely unexplored. In this study, we investigated the expression profiles of the two most important enzymes of the miRNA machinery, Drosha and Dicer, which were closely correlated with nasopharyngeal carcinoma (NPC) and patient survival.
METHODS: Dicer and Drosha mRNA levels were detected by quantitative real-time reverse transcriptase polymerase chain reaction (qRT-PCR) using 24 NPC tissues, 7 normal nasopharyngeal epithelium samples (NPE) and NPC cell lines. In addition, protein levels were detected by immunohistochemistry (IHC) using an NPC tissue microarray (TMA), which include 251 NPC and 105 NPE cases. For some NPC patients can not be contacted, the survival data were available only for 146 patients. Kaplan-Meier analysis was performed, and the chi-square and log-rank tests were used to detect significance levels using SPSS 15.0 software.
RESULTS: The mean level of Dicer and Drosha mRNA were significantly down-regulated in NPC tissue specimens and cell lines when compared with controls. The low levels of Dicer and Drosha protein were frequently seen in NPC, and the low expression of Dicer and Drosha protein was significantly correlated with shorter progression-free survival (PFS) and overall survival (OS) of NPC patients.
CONCLUSIONS: We observed that Drosha and Dicer expression was dysregulation in NPC compared with healthy control samples and was significantly correlated with shorter PFS and OS of NPC patients. Therefore, we hypothesise that the expression levels of Dicer and Drosha could be used as potential prognostic biomarkers for NPC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953080     DOI: 10.1007/s00432-011-1058-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  26 in total

Review 1.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

2.  MicroRNA expression in colon adenocarcinoma.

Authors:  Yujiro Kida; Yuan-Ping Han
Journal:  JAMA       Date:  2008-06-11       Impact factor: 56.272

3.  Structural basis for double-stranded RNA processing by Dicer.

Authors:  Ian J Macrae; Kaihong Zhou; Fei Li; Adrian Repic; Angela N Brooks; W Zacheus Cande; Paul D Adams; Jennifer A Doudna
Journal:  Science       Date:  2006-01-13       Impact factor: 47.728

4.  Dicer plays essential roles for retinal development by regulation of survival and differentiation.

Authors:  Atsumi Iida; Toru Shinoe; Yukihiro Baba; Hiroyuki Mano; Sumiko Watanabe
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-06       Impact factor: 4.799

5.  microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma.

Authors:  Ruey-Jen Lin; You-Chin Lin; Jeremy Chen; Huan-Hsien Kuo; Yuan-Yan Chen; Mitchell B Diccianni; Wendy B London; Chih-Hao Chang; Alice L Yu
Journal:  Cancer Res       Date:  2010-08-30       Impact factor: 12.701

6.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

7.  Dicer, Drosha, and outcomes in patients with ovarian cancer.

Authors:  William M Merritt; Yvonne G Lin; Liz Y Han; Aparna A Kamat; Whitney A Spannuth; Rosemarie Schmandt; Diana Urbauer; Len A Pennacchio; Jan-Fang Cheng; Alpa M Nick; Michael T Deavers; Alexandra Mourad-Zeidan; Hua Wang; Peter Mueller; Marc E Lenburg; Joe W Gray; Samuel Mok; Michael J Birrer; Gabriel Lopez-Berestein; Robert L Coleman; Menashe Bar-Eli; Anil K Sood
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

8.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

9.  Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.

Authors:  Wenling Zhang; Zhaoyang Zeng; Yanhong Zhou; Wei Xiong; Songqing Fan; Lan Xiao; Donghai Huang; Zheng Li; Dan Li; Minghua Wu; Xiaoling Li; Shourong Shen; Rong Wang; Li Cao; Ke Tang; Guiyuan Li
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2009-05       Impact factor: 3.848

10.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

View more
  34 in total

Review 1.  Causes and consequences of microRNA dysregulation.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

Review 2.  Dysregulation of microRNA biogenesis machinery in cancer.

Authors:  Akiko Hata; Risa Kashima
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-12-01       Impact factor: 8.250

3.  miR-18a downregulates DICER1 and promotes proliferation and metastasis of nasopharyngeal carcinoma.

Authors:  Xi Chen; Juan Wang; Lei Cheng; Mei-Ping Lu
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 4.  MicroRNA biogenesis pathways in cancer.

Authors:  Shuibin Lin; Richard I Gregory
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

5.  Downregulated expression of Dicer1 predicts inferior survival in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab.

Authors:  Haifeng Zhao; Le Zhang; Shanqi Guo; Tian Yuan; Bing Xia; FuLian Qu; Lianyu Zhang; Yizhuo Zhang
Journal:  Med Oncol       Date:  2014-09-07       Impact factor: 3.064

6.  Down-regulation of Dicer expression in cervical cancer tissues.

Authors:  Hongqin Zhao; Xiance Jin; Huafang Su; Xia Deng; Ya Fang; Lanxiao Shen; Congying Xie
Journal:  Med Oncol       Date:  2014-03-28       Impact factor: 3.064

7.  Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients.

Authors:  Hailong Zhang; Yixuan Hou; Liyun Xu; Zongyue Zeng; Siyang Wen; Yan-E Du; Kexin Sun; Jiali Yin; Lei Lang; Xiaoli Tang; Manran Liu
Journal:  Dig Dis Sci       Date:  2015-12-22       Impact factor: 3.199

Review 8.  miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.

Authors:  Rajesha Rupaimoole; George A Calin; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Discov       Date:  2016-02-10       Impact factor: 39.397

Review 9.  microRNA involvement in human cancer.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  Carcinogenesis       Date:  2012-04-03       Impact factor: 4.944

10.  Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma.

Authors:  Na Liu; Rui-Xue Cui; Qing-Mei He; Bi-Jun Huang; Ying Sun; Dan Xie; Jing Zeng; Hui-Yun Wang; Jun Ma
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.